Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 519

Results For "MED"

5356 News Found

Covaxin receives approval from Hungary
Biotech | August 05, 2021

Covaxin receives approval from Hungary

More countries recognise Covaxin


NPPA issues notice to manufacturers and importers of knee implants
Policy | August 05, 2021

NPPA issues notice to manufacturers and importers of knee implants

The data should be submitted by August 12th 2021


Biotech-PRIDE guidelines released
Biotech | August 05, 2021

Biotech-PRIDE guidelines released

Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.


Novavax signs agreement with European Commission for COVID19 vaccine
Biotech | August 05, 2021

Novavax signs agreement with European Commission for COVID19 vaccine

Deal for 100 million doses with additional 100 million through 2023


ACG Films & Foils partners Danapak Flexibles A/S for the Indian market
Packaging | August 05, 2021

ACG Films & Foils partners Danapak Flexibles A/S for the Indian market

Innovative solutions and a deep understanding of the market makes this a unique combination


Alembic gets USFDA nod for Clomipramine Hydrochloride
News | August 05, 2021

Alembic gets USFDA nod for Clomipramine Hydrochloride

It had an estimated market size of US $ 32 million as of June 2021


IPCA Labs  reports Q1FY22 net at Rs 306.66 Cr
News | August 05, 2021

IPCA Labs reports Q1FY22 net at Rs 306.66 Cr

Total income grew in the quarter


Caplin Point Laboratories posts consolidated PAT in Q1FY22 at Rs 70.85 Cr
News | August 05, 2021

Caplin Point Laboratories posts consolidated PAT in Q1FY22 at Rs 70.85 Cr

EPS climbs to Rs 9.25 for the quarter


Clarivate  acquires Bioinfogate
Digitisation | August 05, 2021

Clarivate acquires Bioinfogate

Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences


Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF
Drug Approval | August 05, 2021

Combinations of Sputnik V component with other vaccines demonstrate favourable results: RDIF

AstraZeneca, Sinopharm and Moderna were part of the study